1. Ge, Deyong, Shao, Yuhan, Wang, Mengjie, Mu, Min, Tao, Xinrong. 2021. RNA-seq-Based Screening in Coal Dust-Treated Cells Identified PHLDB2 as a Novel Lung Cancer-Related Molecular Marker. In BioMed research international, 2021, 1978434. doi:10.1155/2021/1978434. https://pubmed.ncbi.nlm.nih.gov/34337001/
2. Eom, Sangmi, Lee, Chaeyoung. 2011. Functions of intronic nucleotide variants in the gene encoding pleckstrin homology like domain beta 2 (PHLDB2) on susceptibility to vascular dementia. In The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 14, 227-32. doi:10.3109/15622975.2011.630407. https://pubmed.ncbi.nlm.nih.gov/22111664/
3. Li, Hongyu, Wang, Ziyi, Liang, Huiting, Zhuang, Zehang, Hou, Jinsong. 2024. Depletion of PHLDB2 Suppresses Epithelial-Mesenchymal Transition and Enhances Anti-Tumor Immunity in Head and Neck Squamous Cell Carcinoma. In Biomolecules, 14, . doi:10.3390/biom14020232. https://pubmed.ncbi.nlm.nih.gov/38397469/
4. Wang, Huan, Wang, Liya, Zheng, Qiming, Li, Gonghui, Lu, Jieyang. 2021. Oncometabolite L-2-hydroxyglurate directly induces vasculogenic mimicry through PHLDB2 in renal cell carcinoma. In International journal of cancer, 148, 1743-1755. doi:10.1002/ijc.33435. https://pubmed.ncbi.nlm.nih.gov/33320958/
5. Chen, Geng, Zhou, Tong, Li, Yang, Yu, Zhenxiang, Sun, Liankun. 2017. p53 target miR-29c-3p suppresses colon cancer cell invasion and migration through inhibition of PHLDB2. In Biochemical and biophysical research communications, 487, 90-95. doi:10.1016/j.bbrc.2017.04.023. https://pubmed.ncbi.nlm.nih.gov/28392396/
6. Baskys, Andrius. . Integration of genomic information in development of pharmacological vascular dementia prevention and treatment strategies. In Journal of Alzheimer's disease : JAD, 42 Suppl 3, S267-76. doi:10.3233/JAD-140003. https://pubmed.ncbi.nlm.nih.gov/25024308/
智鼠故事 
